Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gary A Zarkin

Showing results (31-40 of 88) with videos related to

Pageof 9
Sort By:
Addiction (Abingdon, England)|August 2, 2022
Modeling the impact of COVID-19 pandemic-driven increases in alcohol consumption on health outcomes and hospitalization costs in the United StatesCarolina Barbosa, William N Dowd, Simon J Neuwahl, et al.
Alcohol and Alcoholism (Oxford, Oxfordshire)|October 13, 2006
Brief interventions for at-risk drinking: patient outcomes and cost-effectiveness in managed care organizationsThomas F Babor, John C Higgins-Biddle, Deborah Dauser, et al.
Journal of Studies on Alcohol|January 28, 2004
The costs of screening and brief intervention for risky alcohol useGary A Zarkin, Jeremy W Bray, Keith L Davis, et al.
Addiction Science & Clinical Practice|February 1, 2022
Rural and urban differences in undersupply of buprenorphine provider availability in the United States, 2018Kevin P Conway, Dalia Khoury, Rainer Hilscher, et al.
Journal of Substance Abuse Treatment|February 24, 2018
Cost and cost-effectiveness of computerized vs. in-person motivational interventions in the criminal justice systemAlexander J Cowell, Gary A Zarkin, Brendan J Wedehase, et al.
Medical Care|January 17, 2007
The effect of screening and brief intervention for risky drinking on health care utilization in managed care organizationsJeremy W Bray, Gary A Zarkin, Keith L Davis, et al.
Drug and Alcohol Dependence Reports|October 2, 2025
Identifying Opioid Treatment Programs in Medicaid claims data to support quality improvementBarrett Wallace Montgomery, Tami L Mark, William Dowd, et al.
Archives of General Psychiatry|October 8, 2008
Cost and cost-effectiveness of the COMBINE study in alcohol-dependent patientsGary A Zarkin, Jeremy W Bray, Arnie Aldridge, et al.
Drug and Alcohol Dependence|January 13, 2023
Cost and cost-effectiveness of abstinence contingent wage supplementsStephen Orme, Gary A Zarkin, Jackson Luckey, et al.
BMJ Open|June 15, 2019
Vaping cannabis among adolescents: prevalence and associations with tobacco use from a cross-sectional study in the USASarah D Kowitt, Amira Osman, Clare Meernik, et al.
Pageof 9

Showing results (31-40 of 88) with videos related to

Sort By:
Pageof 9
Addiction (Abingdon, England)|August 2, 2022
Modeling the impact of COVID-19 pandemic-driven increases in alcohol consumption on health outcomes and hospitalization costs in the United StatesCarolina Barbosa, William N Dowd, Simon J Neuwahl, et al.
Alcohol and Alcoholism (Oxford, Oxfordshire)|October 13, 2006
Brief interventions for at-risk drinking: patient outcomes and cost-effectiveness in managed care organizationsThomas F Babor, John C Higgins-Biddle, Deborah Dauser, et al.
Journal of Studies on Alcohol|January 28, 2004
The costs of screening and brief intervention for risky alcohol useGary A Zarkin, Jeremy W Bray, Keith L Davis, et al.
Addiction Science & Clinical Practice|February 1, 2022
Rural and urban differences in undersupply of buprenorphine provider availability in the United States, 2018Kevin P Conway, Dalia Khoury, Rainer Hilscher, et al.
Journal of Substance Abuse Treatment|February 24, 2018
Cost and cost-effectiveness of computerized vs. in-person motivational interventions in the criminal justice systemAlexander J Cowell, Gary A Zarkin, Brendan J Wedehase, et al.
Medical Care|January 17, 2007
The effect of screening and brief intervention for risky drinking on health care utilization in managed care organizationsJeremy W Bray, Gary A Zarkin, Keith L Davis, et al.
Drug and Alcohol Dependence Reports|October 2, 2025
Identifying Opioid Treatment Programs in Medicaid claims data to support quality improvementBarrett Wallace Montgomery, Tami L Mark, William Dowd, et al.
Archives of General Psychiatry|October 8, 2008
Cost and cost-effectiveness of the COMBINE study in alcohol-dependent patientsGary A Zarkin, Jeremy W Bray, Arnie Aldridge, et al.
Drug and Alcohol Dependence|January 13, 2023
Cost and cost-effectiveness of abstinence contingent wage supplementsStephen Orme, Gary A Zarkin, Jackson Luckey, et al.
BMJ Open|June 15, 2019
Vaping cannabis among adolescents: prevalence and associations with tobacco use from a cross-sectional study in the USASarah D Kowitt, Amira Osman, Clare Meernik, et al.
Pageof 9